Blueprint Medicines Corporation (NASDAQ:BPMC) Q3 2023 Earnings Call Transcript October 26, 2023 Blueprint Medicines Corporation beats earnings expectations. Reported EPS is $-2.2, expectations were $-2.39. Operator: Good morning. My name is Elliot and I will be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines’ Third Quarter […]